ICS+LABA Vs. ICS+LABA+Omalizumab: Impact on Asthma Control and Gene Expression

Clinical trial NCT06869382 · COMPLETED

Trial details

NCT number: NCT06869382
Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Asthma Patients

Start date: 2023-01-01
Primary completion: 2023-12-31
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.